Detailed answers about NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED, including incorporation, status, business activity, and accounts information.
When was NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED founded?
NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED was officially incorporated on 8 June 2025 and is registered under company number 16503408. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED?
NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED do?
NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED operates in the following sectors: 86220 - Specialists medical practice activities, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED's registered address?
The registered office address of NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED is 11 PRINCE ALBERT ROAD, WAKEFIELD, WEST YORKSHIRE, ENGLAND, WF1 2FP. This is the official address filed with Companies House for legal and statutory correspondence.
Is NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED financially stable?
Financial accounts for NR HEALTH AND HORMONE CLINIC PRIVATE LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.